Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc.（ENDV）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ENDV · 截至 2026年6月9日
活动摘要
买入笔数
54
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Endonovo Therapeutics, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ENDV 季度内部人买卖趋势
ENDV 内幕交易卖出 · ENDV 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
ENDV 高管卖出股份 · ENDV 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jul 1, 2020 | Collier Alan Brian CEO | Purchase | 100 | $10 | Form 4 |
| Jul 1, 2020 | Collier Alan Brian CEO | Purchase | 100 | $10 | Form 4 |
| Jun 30, 2020 | Collier Alan Brian CEO | Purchase | 200 | $21 | Form 4 |
| Feb 22, 2020 | Collier Alan Brian Director | Purchase | 100 | $96 | Form 4 |
| Jan 2, 2020 | Collier Alan Brian Ceo | Purchase | 100 | $175 | Form 4 |
| Dec 30, 2019 | Collier Alan Brian Ceo | Purchase | 100 | $225 | Form 4 |
| Dec 20, 2019 | Collier Alan Brian Ceo | Purchase | 100 | $0 | Form 4 |
| Dec 16, 2019 | Collier Alan Brian Ceo | Purchase | 500 | $1 | Form 4 |
| Dec 12, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $2 | Form 4 |
| Dec 11, 2019 | Collier Alan Brian Ceo | Purchase | 100 | $0 | Form 4 |
| Dec 11, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $2 | Form 4 |
| Dec 10, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $3 | Form 4 |
| Dec 10, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $6 | Form 4 |
| Dec 5, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $6 | Form 4 |
| Dec 4, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $6 | Form 4 |
| Dec 4, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $6 | Form 4 |
| Dec 2, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $6 | Form 4 |
| Nov 29, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $6 | Form 4 |
| Nov 27, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $7 | Form 4 |
| Nov 27, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $4 | Form 4 |
| Nov 25, 2019 | Collier Alan Brian Ceo | Purchase | 2,000 | $7 | Form 4 |
| Nov 22, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $4 | Form 4 |
| Nov 22, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $4 | Form 4 |
| Nov 20, 2019 | Collier Alan Brian Ceo | Purchase | 1,000 | $4 | Form 4 |
| Nov 4, 2019 | Collier Alan Brian CEO | Purchase | 10,000 | $58 | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ENDV 内幕交易
ENDV 内幕交易
Endonovo Therapeutics, Inc.（ENDV）内幕交易数据来源于公司内部人（包括ENDV）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。ENDV内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Endonovo Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ENDV 内幕交易 · 5个问题Endonovo Therapeutics, Inc.（ENDV）的内部人包括高管和董事，如ENDV等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026